On Monday, Cg Oncology Inc (NASDAQ: CGON) opened higher 25.03% from the last session, before settling in for the closing price of $22.37. Price fluctuations for CGON have ranged from $14.80 to $46.99 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 122.33% over the last five years. Company’s average yearly earnings per share was noted -26.26% at the time writing. With a float of $46.04 million, this company’s outstanding shares have now reached $76.15 million.
The firm has a total of 113 workers. Let’s measure their productivity. In terms of profitability, gross margin is 99.03%, operating margin of -10067.25%, and the pretax margin is -7729.32%.
Cg Oncology Inc (CGON) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cg Oncology Inc is 39.60%, while institutional ownership is 67.15%. The most recent insider transaction that took place on Mar 17 ’25, was worth 28,000. In this transaction Director of this company sold 1,000 shares at a rate of $28.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 17 ’25, when Company’s Director proposed sale 4,000 for $27.80, making the entire transaction worth $111,200.
Cg Oncology Inc (CGON) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -26.26% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
Check out the current performance indicators for Cg Oncology Inc (CGON). In the past quarter, the stock posted a quick ratio of 35.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1869.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.16, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.58 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Analysing the last 5-days average volume posted by the [Cg Oncology Inc, CGON], we can find that recorded value of 2.96 million was better than the volume posted last year of 0.95 million. As of the previous 9 days, the stock’s Stochastic %D was 86.90%. Additionally, its Average True Range was 2.25.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 60.05%, which indicates a significant decrease from 75.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 109.21% in the past 14 days, which was higher than the 74.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.21, while its 200-day Moving Average is $31.40. Now, the first resistance to watch is $30.99. This is followed by the second major resistance level at $34.01. The third major resistance level sits at $35.72. If the price goes on to break the first support level at $26.26, it is likely to go to the next support level at $24.55. Should the price break the second support level, the third support level stands at $21.53.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
There are currently 76,217K shares outstanding in the company with a market cap of 2.13 billion. Presently, the company’s annual sales total 1,140 K according to its annual income of -88,040 K. Last quarter, the company’s sales amounted to 460 K and its income totaled -31,800 K.
